{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T05:44:30Z","timestamp":1789969470260,"version":"4.0.1"},"reference-count":36,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2008,7,17]],"date-time":"2008-07-17T00:00:00Z","timestamp":1216252800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Dermatology"],"published-print":{"date-parts":[[2009,3]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold> Pemphigus vulgaris (PV) is an autoimmune bullous disease caused by immunoglobulin G (IgG) autoantibodies against desmoglein 3 (Dsg3). We have generated an active disease mouse model for PV by adoptive transfer of Dsg3<jats:sup>\u2212\/\u2212<\/jats:sup> lymphocytes. In this study, we investigated the benefits and limitations of this model as a tool to evaluate various immunosuppressive therapeutic strategies. We used the following three measurements to evaluate the effects of the drugs during the time course: Dsg3 enzyme\u2010linked immunosorbent assay scores that represent the level of production of anti\u2010Dsg3 IgG, body weight loss that reflects the severity of oral erosions and PV score that reflects the extent of skin lesions. We examined various immunosuppressive agents currently used to treat patients with PV model mice in preventive protocol. Cyclophosphamide almost completely suppressed the production of anti\u2010Dsg3 IgG, development of body weight loss and the appearance of the PV phenotype in contrast with the control group without the drug. Azathioprine, cyclosporin A and tacrolimus hydrate also showed suppressive effects to various degrees. However, methylprednisolone and dexamethasone failed to show significant effects in contrast to the findings reported in humans. Knowing the advantages and limitations of this model will provide an important foundation for the future evaluation and development of novel therapeutic strategies.<\/jats:p>","DOI":"10.1111\/j.1600-0625.2008.00776.x","type":"journal-article","created":{"date-parts":[[2008,7,17]],"date-time":"2008-07-17T07:19:48Z","timestamp":1216279188000},"page":"252-260","source":"Crossref","is-referenced-by-count":20,"title":["Pemphigus mouse model as a tool to evaluate various immunosuppressive therapies"],"prefix":"10.1111","volume":"18","author":[{"given":"Yujiro","family":"Takae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeji","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Amagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,2,18]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1600-0625.2006.00499_1.x","article-title":"Are desmoglein autoantibodies essential for the immunopathogenesis of pemphigus vulgaris, or just \u201cwitnesses of disease\u201d?","volume":"15","author":"Amagai M","year":"2006","journal-title":"Exp Dermatol"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.159.4.2010"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.04838.x"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.02752.x"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.9.5439"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2007.00615.x"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI8748"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.2302\/kjm.51.133"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.06056.x"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0022-202x.2001.01643.x"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0031-9384(95)00135-6"},{"key":"e_1_2_7_13_2","first-page":"333","article-title":"Long term administration of cyclophosphamide in MRL\/1 mice. I. The effects on the development of immunological abnormalities and lupus nephritis","volume":"55","author":"Shiraki M","year":"1984","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_7_14_2","first-page":"290","article-title":"Azathioprine administration to NZB X NZW hybrid mice with lupus nephritis: beneficial effect complicated by development of malignant lymphomas","volume":"79","author":"Casey T P","year":"1973","journal-title":"N Z Med J"},{"key":"e_1_2_7_15_2","first-page":"377","article-title":"Cyclosporine therapy suppresses ocular and lacrimal gland disease in MRL\/Mp\u2010lpr\/lpr mice","volume":"37","author":"Jabs D A","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.20165"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01971229"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5955(99)00147-1"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5955(99)00148-3"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.3109\/03009748809096781"},{"key":"e_1_2_7_21_2","first-page":"61","article-title":"Ongoing immunologic activity after short courses of pulse cyclophosphamide in the NZB\/W murine model of systemic lupus erythematosus","volume":"24","author":"Austin H A III","year":"1997","journal-title":"J Rheumatol"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780190108"},{"key":"e_1_2_7_23_2","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.4049\/jimmunol.123.5.2156","article-title":"Effect of cyclophosphamide on suppressor cell activity in mice unresponsive to EAE","volume":"123","author":"Lando Z","year":"1979","journal-title":"J Immunol"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(91)90360-B"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115968"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117349"},{"key":"e_1_2_7_27_2","first-page":"95","article-title":"Interspecies correlation of plasma concentration history of methotrexate (NSC\u2010740)","volume":"54","author":"Dedrick R","year":"1970","journal-title":"Cancer Chemother Rep"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M309000200"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri853"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2004.01831.x"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2004.09.003"},{"key":"e_1_2_7_32_2","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1001\/archderm.1992.04530010064010","article-title":"Treatment of pemphigus vulgaris with pulse intravenous cyclophosphamide","volume":"128","author":"Pandya A G","year":"1992","journal-title":"Arch Dermatol"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.135.1.57"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1973.01620180007002"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(08)81506-X"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(88)70132-2"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2004.01499.x"}],"container-title":["Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0625.2008.00776.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0625.2008.00776.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T08:46:08Z","timestamp":1697359568000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0625.2008.00776.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,18]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["10.1111\/j.1600-0625.2008.00776.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0625.2008.00776.x","archive":["Portico"],"relation":{},"ISSN":["0906-6705","1600-0625"],"issn-type":[{"value":"0906-6705","type":"print"},{"value":"1600-0625","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,18]]}}}